tirzepatide exercise interaction weight loss 2025 Frontiers ACE - Certified™: June 2025

Originally approved for type 2 diabetes, Mounjaro is now MHRA-approved in the UK for weight management in adults 18 and over

Participants receiving the highest maintenance dose lost approximately 20-22% of their baseline body weight, while those on lower doses experienced 15-19% reductions

It is important to note that tirzepatide is also marketed under the brand name Mounjaro for type 2 diabetes management, though the approved indications differ between these formulations

This tricks your brain into thinking youre eating more than you really are

If you're obtaining a Tirzepatide prescription online, make sure to check the storage guidelines as soon as you receive your medication to ensure it remains safe and effective